Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance

Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance

Item
http://www.wikidata.org/entity/Q28081606
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.Synthesis and preliminary PET imaging of 11C and 18F isotopologues of the ROS1/ALK inhibitor lorlatinibAlectinib (CH5424802) antagonizes ABCB1- and ABCG2-mediated multidrug resistance in vitro, in vivo and ex vivoThe second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model.Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer.The role of alectinib in the treatment of advanced ALK-rearranged non-small-cell lung cancer.TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALKDoes ALK-rearrangement predict favorable response to the therapy of bevacizumab plus pemetrexed in advanced non-small-cell lung cancer? Case report and literature review.Precision oncology: neither a silver bullet nor a dream.Antitumor activity of kinetochore-associated protein 2 siRNA against lung cancer patient-derived tumor xenografts.Exposure-response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer.
P2860

Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance

Item
http://www.wikidata.org/entity/Q28081606
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Alectinib: a novel second gene ...... clinically-acquired resistance
@ast
Alectinib: a novel second gene ...... clinically-acquired resistance
@en
Alectinib: a novel second gene ...... clinically-acquired resistance
@nl
type
label
Alectinib: a novel second gene ...... clinically-acquired resistance
@ast
Alectinib: a novel second gene ...... clinically-acquired resistance
@en
Alectinib: a novel second gene ...... clinically-acquired resistance
@nl
prefLabel
Alectinib: a novel second gene ...... clinically-acquired resistance
@ast
Alectinib: a novel second gene ...... clinically-acquired resistance
@en
Alectinib: a novel second gene ...... clinically-acquired resistance
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Alectinib: a novel second gene ...... clinically-acquired resistance
@en
P2093
P2860
P304
P31
P356
10.1016/J.APSB.2014.12.007
P407
P433
P478
P577
P5875
P698
P921
P932